We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

13 hedge funds and large institutions have $120K invested in AIM ImmunoTech in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.25% less ownership

Funds ownership: 3.96% → 3.72% (-0.25%)

13% less funds holding

Funds holding: 15 → 13 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

59% less capital invested

Capital invested by funds: $294K → $120K (-$174K)

Holders
13
Holders Change
-2
Holders Change %
-13.33%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DS
DRW Securities
Illinois
+$48.6K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.2K
3
TRCT
Tower Research Capital (TRC)
New York
+$231
4
UBS Group
UBS Group
Switzerland
+$139
5
Bank of America
Bank of America
North Carolina
+$2

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$79.1K
2
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$137
3
HI
Harbour Investments
Wisconsin
-$27
4
Wells Fargo
Wells Fargo
California
-$11
Name Holding Trade Value Shares
Change 		Change in
Stake
DS
1
DRW Securities
Illinois
$78.6K +$48.6K +26,281 +61%
Vanguard Group
2
Vanguard Group
Pennsylvania
$19.8K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$19.6K +$2.2K +1,191 +7%
Morgan Stanley
4
Morgan Stanley
New York
$976 +$2 +1 +0.1%
UBS Group
5
UBS Group
Switzerland
$428 +$139 +75 +25%
CB
6
Community Bank
New York
$147 – – –
TRCT
7
Tower Research Capital (TRC)
New York
$141 +$231 +125 New
Bank of America
8
Bank of America
North Carolina
$32 +$2 +1 +4%
Osaic Holdings
9
Osaic Holdings
Arizona
$16 – – –
HI
10
Hoey Investments
Pennsylvania
$12 – – –
SPIA
11
Steward Partners Investment Advisory
New York
$2 – – –
FFA
12
Farther Finance Advisors
California
$1 – – –
ISWM
13
Intesa Sanpaolo Wealth Management
$1 +$2 +1 New
SM
14
Sabby Management
Florida
– -$79.1K -28,884 Closed
PNC Financial Services Group
15
PNC Financial Services Group
Pennsylvania
– -$137 -50 Closed
HI
16
Harbour Investments
Wisconsin
– -$27 -10 Closed
Wells Fargo
17
Wells Fargo
California
– -$11 -4 Closed

AIM Hedge Fund Activity: Q4 2025 in Review

13 of the 8,252 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q4 2025, worth a combined $120K — down 59% from $294K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of AIM and 2 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 5 added.

The largest buyer was DRW Securities, adding an estimated $48.6K. The largest seller was Sabby Management, exiting entirely with an estimated $79.1K sold.

  • 13 institutional investors held AIM ImmunoTech (AIM) as of Q4 2025, down from 15 in Q3 2025.
  • Funds reported $120K of AIM ImmunoTech stock for Q4 2025, down 59% quarter-over-quarter.
  • 2 funds opened new AIM ImmunoTech positions in Q4 2025 and 4 closed out, a net change of -2 holders.
  • The largest AIM ImmunoTech buyer in Q4 2025 was DRW Securities, an estimated $48.6K added.
  • The largest AIM ImmunoTech seller in Q4 2025 was Sabby Management, an estimated $79.1K sold.

Based on aggregated 13F filings for Q4 2025.